Related Experiment Video
Updated: May 22, 2026

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
Published on: January 28, 2021
Treatment options for severe hypertriglyceridemia (SHTG): the role of apheresis
Nils Ewald1, Hans-Ulrich Kloer
1Third Medical Department, University Hospital Giessen and Marburg, Giessen Site, Klinikstr. 33, 35392 Giessen, Germany. nils.ewald@innere.med.uni-giessen.de
Insights
Severe hypertriglyceridemia (SHTG) requires rapid triglyceride lowering. Plasmapheresis is a safe and effective treatment for SHTG, especially in emergencies like pancreatitis.
Area of Science:
- Cardiology
- Metabolic Disorders
- Medical Technology
Background:
- Hypertriglyceridemia is linked to severe conditions like acute pancreatitis and coronary artery disease.
- Severe hypertriglyceridemia (SHTG), defined as triglycerides > 1,000 mg/dL, necessitates prompt reduction of plasma triglycerides (TG).
Purpose of the Study:
- To review the current literature on therapeutic apheresis for severe hypertriglyceridemia.
- To evaluate the safety and efficacy of plasmapheresis in managing SHTG.
Main Methods:
- Literature review of existing studies on apheresis for SHTG.
- Analysis of plasmapheresis as a treatment modality for hypertriglyceridemic pancreatitis.
Main Results:
- Plasmapheresis is identified as a safe and effective therapeutic option for SHTG.
- Apheretic treatment can remove the causative factors of pancreatic inflammation.
- Early intervention with apheresis appears to yield optimal outcomes.
Conclusions:
- Plasmapheresis is a valuable tool for managing SHTG, particularly in acute settings.
- The early application of apheresis is recommended for best results in SHTG management.
- High costs and limited availability restrict the widespread use of plasmapheresis.
Abstract:
Hypertriglyceridemia is associated with a number of severe diseases such as acute pancreatitis and coronary artery disease. In severe hypertriglyceridemia (SHTG, triglycerides > 1,000 mg/dL), rapid lowering of plasma triglycerides (TG) has to be achieved. Treatment regimes include nutritional intervention, the use of antihyperlipidemic drugs, and therapeutic apheresis. Apheretic treatment is indicated in medical emergencies such as hypertriglyceridemic pancreatitis. Reviewing the current literature, plasmapheresis appears to be a safe and useful therapeutic tool in patients suffering from SHTG. Apheretic treatment is able to remove the causative agent for pancreatic inflammation. Data suggests that the use of apheresis should be performed as early as possible in order to achieve best results. The use of plasmapheresis, however, is limited due to the rather high costs and the limited availability of the procedure.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Venous Thrombosis III: Interprofessional Care
Cholesterol: Significance and Regulation
Considering cholesterol and...
